Design and synthesis of a novel class of carbonic anhydrase-IX inhibitor 1-(3-(phenyl/4-fluorophenyl)-7-imino-3H-[1,2,3]triazolo[4,5d]pyrimidin 6(7H)yl)urea.

Carbonic anhydrase IX (CAIX) is a promising target in cancer therapy especially in the case of hypoxia-induced tumors. The selective inhibition of CA isozymes is a challenging task in drug design and discovery process. Here, we performed fluorescence-binding studies and inhibition assay combined with molecular docking and molecular dynamics (MD) simulation analyses to determine the binding affinity of two synthesized triazolo-pyrimidine urea derived (TPUI and TPUII) compounds with CAIX and CAII. Fluorescence binding results are showing that molecule TPUI has an excellent binding-affinity for CAIX (kD=0.048μM). The TPUII also exhibits an appreciable binding affinity (kD=7.52μM) for CAIX. TPUI selectively inhibits CAIX as compared to TPUII in the 4-NPA assay. Docking studies show that TPUI is spatially well-fitted in the active site cavity of CAIX, and is involve in H-bond interactions with His94, His96, His119, Thr199 and Thr200. MD simulation studies revealed that TPUI efficiently binds to CAIX and essential active site residual interaction is consistent during the entire simulation of 40ns. These studies suggest that TPUI appeared as novel class of CAIX inhibitor, and may be used as a lead molecule for the development of potent and selective CAIX inhibitor for the hypoxia-induced cancer therapy.

[1]  C. Supuran,et al.  Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. , 2003, Bioorganic & medicinal chemistry letters.

[2]  Sharmistha Dey,et al.  Curcumin specifically binds to the human calcium–calmodulin-dependent protein kinase IV: fluorescence and molecular dynamics simulation studies , 2016, Journal of biomolecular structure & dynamics.

[3]  C. Supuran,et al.  4-Functionalized 1,3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII. , 2014, Bioorganic & medicinal chemistry.

[4]  F. Ahmad,et al.  Molecular basis of the structural stability of hemochromatosis factor E: A combined molecular dynamic simulation and GdmCl‐induced denaturation study , 2016, Biopolymers.

[5]  C. Supuran,et al.  Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors , 2015, Journal of enzyme inhibition and medicinal chemistry.

[6]  W. Sly,et al.  Structure, function and applications of carbonic anhydrase isozymes. , 2013, Bioorganic & medicinal chemistry.

[7]  C. Supuran,et al.  Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII. , 2014, Bioorganic & medicinal chemistry.

[8]  C. Supuran,et al.  Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. , 2010, Journal of medicinal chemistry.

[9]  C. Daniliuc,et al.  Monocyclic β-lactam and unexpected oxazinone formation: synthesis, crystal structure, docking studies and antibacterial evaluation , 2016, Journal of enzyme inhibition and medicinal chemistry.

[10]  Krishna Bisetty,et al.  Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition. , 2015, Omics : a journal of integrative biology.

[11]  S. Marcié,et al.  Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis , 2013, Front. Oncol..

[12]  G. Fishman,et al.  THE USE OF CARBONIC ANHYDRASE INHIBITORS IN THE RETREATMENT OF CYSTIC MACULAR LESIONS IN RETINITIS PIGMENTOSA AND X-LINKED RETINOSCHISIS , 2011, Retina.

[13]  C. Supuran,et al.  Design, solid-phase synthesis, and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors. , 2010, Bioorganic & medicinal chemistry.

[14]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II and IX with some 1,3,4-oxadiazole- and 1,2,4-triazole-thiols , 2008 .

[15]  C. Supuran,et al.  Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII. , 2015, Bioorganic & medicinal chemistry.

[16]  C. Supuran,et al.  Attachment of carbohydrates to methoxyaryl moieties leads to highly selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII. , 2014, Bioorganic & medicinal chemistry.

[17]  Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. , 2005, Bioorganic & medicinal chemistry letters.

[18]  W. Sly,et al.  Expression Patterns and Subcellular Localization of Carbonic Anhydrases Are Developmentally Regulated during Tooth Formation , 2014, PloS one.

[19]  Z. Kaplancıklı,et al.  Synthesis and evaluation of new thiadiazole derivatives as potential inhibitors of human carbonic anhydrase isozymes (hCA-I and hCA-II) , 2015, Journal of enzyme inhibition and medicinal chemistry.

[20]  C. Supuran,et al.  Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site. , 2015, Journal of medicinal chemistry.

[21]  C. Supuran,et al.  Carbonic anhydrase inhibitors: design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives. , 2014, ACS medicinal chemistry letters.

[22]  J. Kumar,et al.  Search of potential inhibitor against New Delhi metallo-beta-lactamase 1 from a series of antibacterial natural compounds , 2013, Journal of natural science, biology, and medicine.

[23]  F. Ahmad,et al.  PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4. , 2015, Journal of molecular graphics & modelling.

[24]  A. Liljas,et al.  Refined structure of the acetazolamide complex of human carbonic anhydrase II at 1.9 A. , 1990, International Journal of Biological Macromolecules.

[25]  C. Supuran,et al.  Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII. , 2014, Bioorganic & medicinal chemistry.

[26]  N. Devika,et al.  Molecular modeling and simulation of the human eNOS reductase domain, an enzyme involved in the release of vascular nitric oxide , 2014, Journal of Molecular Modeling.

[27]  Ronald J. Quinn,et al.  Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. , 2009, Journal of the American Chemical Society.

[28]  Brendan L Wilkinson,et al.  Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. , 2007, Journal of medicinal chemistry.

[29]  S. Carradori,et al.  Out of the active site binding pocket for carbonic anhydrase inhibitors. , 2015, Chemical communications.

[30]  Matthew L. Danielson,et al.  Computer-aided drug design platform using PyMOL , 2011, J. Comput. Aided Mol. Des..

[31]  W. Sly,et al.  Expression of cancer‐related carbonic anhydrases IX and XII in normal skin and skin neoplasms , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[32]  W. Sly,et al.  Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours , 2006, Histopathology.

[33]  Faez Iqbal Khan,et al.  Large scale analysis of the mutational landscape in β-glucuronidase: A major player of mucopolysaccharidosis type VII. , 2016, Gene.

[34]  Dirk Neumann,et al.  A new Lamarckian genetic algorithm for flexible ligand‐receptor docking , 2010, J. Comput. Chem..

[35]  M. I. Hassan,et al.  Structure‐guided design of peptidic ligand for human prostate specific antigen , 2007, Journal of peptide science : an official publication of the European Peptide Society.

[36]  C. Supuran,et al.  Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? , 2012, Chemical reviews.

[37]  Chunmei Yang,et al.  Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening. , 2013, Bioorganic & medicinal chemistry letters.

[38]  C. Supuran,et al.  Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors. , 2011, Journal of medicinal chemistry.

[39]  De-Qing Shi,et al.  Synthesis and biological activity of 3-[(6-chloropyridin-3-yl)methyl]-6-substituted-6,7-dihydro-3H-1,2,3-triazolo[4,5-d]-pyrimidin-7-imines , 2008 .

[40]  C. Supuran,et al.  Metallocene-based inhibitors of cancer-associated carbonic anhydrase enzymes IX and XII. , 2012, Journal of medicinal chemistry.

[41]  C. De Monte,et al.  Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors. , 2013, Bioorganic & medicinal chemistry letters.

[42]  C. Supuran.  Development of small molecule carbonic anhydrase IX inhibitors , 2008, BJU international.

[43]  Brendan L Wilkinson,et al.  A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing". , 2006, Journal of medicinal chemistry.

[44]  F. Ahmad,et al.  In vitro and in silico studies of urea-induced denaturation of yeast iso-1-cytochrome c and its deletants at pH 6.0 and 25 °C , 2015, Journal of biomolecular structure & dynamics.

[45]  Hong-Mei Zhang,et al.  Spectroscopic studies on the interaction between silicotungstic acid and bovine serum albumin. , 2007, Journal of pharmaceutical and biomedical analysis.

[46]  F. Ahmad,et al.  Spectroscopic and MD simulation studies on unfolding processes of mitochondrial carbonic anhydrase VA induced by urea , 2016, Journal of biomolecular structure & dynamics.

[47]  F. Ahmad,et al.  Structure guided design of potential inhibitors of human calcium-calmodulin dependent protein kinase IV containing pyrimidine scaffold. , 2016, Bioorganic & medicinal chemistry letters.

[48]  Y. Pocker,et al.  The catalytic versatility of erythrocyte carbonic anhydrase. 3. Kinetic studies of the enzyme-catalyzed hydrolysis of p-nitrophenyl acetate. , 1967, Biochemistry.

[49]  Y. Pocker,et al.  The catalytic versatility of erythrocyte carbonic anhydrase. The enzyme-catalyzed hydrolysis of rho-nitrophenyl acetate. , 1965, Journal of the American Chemical Society.

[50]  A. Scaloni,et al.  Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX , 2009, Proceedings of the National Academy of Sciences.

[51]  VINCENT ZOETE,et al.  SwissParam: A fast force field generation tool for small organic molecules , 2011, J. Comput. Chem..

[52]  J. Ladbury,et al.  Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX. , 2014, Journal of medicinal chemistry.

[53]  Faez Iqbal Khan,et al.  Role of N-terminal residues on folding and stability of C-phycoerythrin: simulation and urea-induced denaturation studies , 2015, Journal of biomolecular structure & dynamics.

[54]  F. Ahmad,et al.  Receptor Chemoprint Derived Pharmacophore Model for Development of CAIX Inhibitors , 2014 .

[55]  M. Tiwari,et al.  Homology modeling and QSAR analysis of 1,3,4-thiadiazole and 1,3,4-triazole derivatives as carbonic anhydrase inhibitors. , 2010, Indian journal of biochemistry & biophysics.